XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,226,000 $ 962,000
Accounts receivable, net of allowance 578,000 513,000
Inventories, net of allowance 256,000 241,000
Prepaid expenses and other current assets 81,000 85,000
Total current assets 2,141,000 1,801,000
Non-current assets    
Equipment and leasehold improvements, net of depreciation 153,000 61,000
Other non-current assets 69,000 69,000
Investment in South Korean joint venture 33,000 48,000
Right of use operating lease, net of amortization 390,000 453,000
Clyra Medical prepaid marketing (Note 8) 591,000 591,000
Total non-current assets 1,236,000 1,222,000
Total assets 3,377,000 3,023,000
Current liabilities:    
Debt obligations, net of discount and amortization (Note 4) 81,000 314,000
Deferred revenue 0 89,000
Customer deposits 137,000 79,000
Current portion of operating lease liability 103,000 103,000
Total current liabilities 1,179,000 1,374,000
Long-term liabilities:    
Long-term debt, noncurrent 247,000 180,000
Operating lease liability, net of current portion 286,000 349,000
Total long-term liabilities 810,000 716,000
Total liabilities 1,989,000 2,090,000
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY (DEFICIT):    
Preferred Series A, $0.00067 Par Value, 50,000,000 Shares Authorized, -0- Shares Issued and Outstanding, at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.00067 Par Value, 400,000,000 Shares Authorized, 268,036,728 and 255,893,726 Shares Issued, at June 30, 2022 and December 31, 2021 179,000 171,000
Additional paid-in capital 146,422,000 143,718,000
Accumulated deficit (142,001,000) (139,121,000)
Accumulated other comprehensive loss (126,000) (115,000)
Total BioLargo Inc. and subsidiaries stockholders’ equity 4,474,000 4,653,000
Non-controlling interest (Note 8) (3,086,000) (3,720,000)
Total stockholders’ equity 1,388,000 933,000
Total liabilities and stockholders’ equity 3,377,000 3,023,000
Entities, Excluding Partially Owned Subsidiary [Member]    
Current liabilities:    
Accounts payable and accrued expenses 663,000 559,000
Long-term liabilities:    
Long-term debt, noncurrent 247,000 180,000
Partially Owned Subsidiary [Member]    
Current liabilities:    
Accounts payable and accrued expenses 195,000 230,000
Long-term liabilities:    
Long-term debt, noncurrent $ 277,000 $ 187,000